BAROSI, GIOVANNI
 Distribuzione geografica
Continente #
NA - Nord America 400
EU - Europa 380
AS - Asia 249
AF - Africa 2
Continente sconosciuto - Info sul continente non disponibili 1
SA - Sud America 1
Totale 1.033
Nazione #
US - Stati Uniti d'America 394
CN - Cina 199
IE - Irlanda 153
IT - Italia 68
FI - Finlandia 53
DE - Germania 50
SG - Singapore 34
SE - Svezia 21
GB - Regno Unito 15
UA - Ucraina 8
CA - Canada 5
BE - Belgio 4
JP - Giappone 4
CZ - Repubblica Ceca 3
IN - India 3
IR - Iran 3
PL - Polonia 3
MU - Mauritius 2
UZ - Uzbekistan 2
AZ - Azerbaigian 1
BR - Brasile 1
ES - Italia 1
EU - Europa 1
FR - Francia 1
HK - Hong Kong 1
KZ - Kazakistan 1
NP - Nepal 1
PA - Panama 1
Totale 1.033
Città #
Dublin 153
Chandler 120
Nanjing 46
Beijing 39
Helsinki 36
Ashburn 33
Jacksonville 27
Boardman 23
Pavia 22
Singapore 20
Nanchang 19
New York 17
Lawrence 16
Medford 16
Princeton 16
Wilmington 14
Hangzhou 13
Shanghai 13
Changsha 12
Hebei 12
Shenyang 12
Tianjin 12
Falkenstein 8
Jiaxing 8
Gallarate 6
Milan 6
Los Angeles 5
Toronto 5
Brussels 4
Tokyo 4
Turin 4
Augusta 3
Brno 3
Hanover 3
Jinan 3
Rome 3
Woodbridge 3
Chicago 2
Orange 2
Piscataway 2
Polska 2
Pune 2
Santa Clara 2
Verona 2
Verrua Po 2
Washington 2
Almaty 1
Americana 1
Andijan 1
Ann Arbor 1
Aosta 1
Ardabil 1
Baku 1
Casorate Sempione 1
Dallas 1
Esslingen am Neckar 1
Fairfield 1
Fuzhou 1
Guangzhou 1
Handan 1
Hong Kong 1
Kathmandu 1
Leawood 1
Modena 1
Monza 1
Munich 1
Norwalk 1
Nuremberg 1
Padova 1
Redmond 1
San Francisco 1
Seattle 1
Segrate 1
Shijiazhuang 1
Taizhou 1
Tashkent 1
Würzburg 1
Zanjan 1
Zhengzhou 1
Totale 810
Nome #
Altered fibronectin expression and deposition by myeloproliferative neoplasm-derived mesenchymal stromal cells 90
Thrombopoietin/TGF-β1 loop regulates megakaryocyte extracellular matrix component synthesis 70
Differential clinical effects of different mutation subtypes in CALR-mutant myeloproliferative neoplasms 69
Thrombopoietin/TGF-β1 Loop Regulates Megakaryocyte Extracellular Matrix Component Synthesis 68
The spleen of patients with myelofibrosis harbors defective mesenchymal stromal cells 68
Phenotypical, Functional and Genetic Characterization of Mesenchymal Stem Cells Derived from the Spleen of Patients with Myelofibrosis. 67
JAK2 exon 14 Skipping in Patients with Primary Myelofibrosis (PMF). 65
Splenic marginal zone cell lymphoma: report of an indolent variant without massive splenomegaly presumably representing an early phase of the disease. 59
EDA fibronectin–TLR4 axis sustains megakaryocyte expansion and inflammation in bone marrow fibrosis 57
Dysregulation of VEGF-induced proangiogenic Ca(2+) oscillations in primary myelofibrosis-derived endothelial colony-forming cells 55
Primary Prophylaxis of Invasive Fungal Diseases in Allogeneic Stem Cell Transplantation: Revised Recommendations from a Consensus Process by Gruppo Italiano Trapianto Midollo Osseo (GITMO) 55
SIE, SIES, GITMO evidence-based guidelines on novel agents (thalidomide, bortezomib, and lenalidomide) in the treatment of multiple myeloma 54
Constitutive STAT5 phosphorylation in CD34+ cells of patients with primary myelofibrosis: Correlation with driver mutation status and disease severity 54
Management of multiple myeloma and related-disorders: guidelines from the Italian Society of Hematology (SIE), Italian Society of Experimental Hematology (SIES) and Italian Group for Bone Marrow Transplantation (GITMO). 53
Deciding when to intervene: a Markov decision process approach 52
Assessment and prevention of cytomegalovirus infection in allogeneic hematopoietic stem cell transplant and in solid organ transplant: A multidisciplinary consensus conference by the Italian GITMO, SITO, and AMCLI societies 48
Defective interaction of mutant calreticulin and SOCE in megakaryocytes from patients with myeloproliferative neoplasms 42
Elevated plasma EDA fibronectin in primary myelofibrosis is determined by high allele burden of JAK2V617F mutation and strongly predicts splenomegaly progression 24
Increased plasma nicotinamide phosphoribosyltransferase is associated with a hyperproliferative phenotype and restrains disease progression in MPN-associated myelofibrosis 18
HEMATOPOIETIC PROGENITOR CELLS EXPRESSING VE-CADHERIN ARE DETECTABLE IN THE SPLEEN OF PATIENTS WITH MYELOFIBROSIS AND ARE IN CLOSE CONTACT WITH MICROVESSELS 8
Circulating Polymorphonuclear Myeloid-Derived Suppressor Cells (PMN-MDSCs) Have a Biological Role in Patients with Primary Myelofibrosis 2
Identifying and addressing unmet clinical needs in primary cutaneous B-cell lymphoma: A consensus-based paper from an ad-hoc international panel 1
Critical concepts and management recommendations for cutaneous T‐cell lymphoma: A consensus‐based position paper from the Italian Group of Cutaneous Lymphoma 1
Totale 1.080
Categoria #
all - tutte 5.247
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 5.247


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202049 0 0 0 0 0 0 0 1 7 21 18 2
2020/202160 5 1 0 11 0 4 0 12 21 5 1 0
2021/2022104 0 0 3 19 1 1 0 5 3 14 13 45
2022/2023337 34 35 3 26 29 25 2 17 153 2 7 4
2023/2024147 19 29 4 4 10 52 0 13 1 4 5 6
2024/2025137 23 23 8 13 6 32 15 17 0 0 0 0
Totale 1.080